Mirum Pharmaceuticals, Inc. MIRM Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s common stock?
- Mirum Pharmaceuticals, Inc. (MIRM) reported common stock of 200M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s common stock decreased by 0.0% year-over-year, from 200M to 200M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s common stock?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s common stock has grown at a 822.1% compound annual growth rate (CAGR), from 3K to 200M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).